Home › Funds › LexAurum Advisors, LLC › PGEN
LexAurum Advisors, LLC position in PGEN
PRECIGEN INC · Health Care
LexAurum Advisors, LLC reported holding 633,533 shares of PGEN (PRECIGEN INC) in its Q3 2026 13F filing — a position valued at US$5.4M, representing 0.61% of its reported portfolio and ranking #38 among its reported holdings. LexAurum Advisors, LLC has disclosed PGEN holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-19 · Source: SEC EDGAR Form 13F-HR
How LexAurum Advisors, LLC's PGEN position evolved
LexAurum Advisors, LLC first disclosed a stake in PGEN in Q3 2023 at 92,666 shares (US$132K). The position peaked in Q3 2026 at 633,533 shares, worth US$5.4M. Across 11 filings, LexAurum Advisors, LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 633,533 shares valued at US$5.4M — a reduction of -4,880 shares quarter over quarter.. Notable position changes include a 208% increase in Q3 2024 (shares rose 18% over the following quarter), a 152% increase in Q4 2024 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 92.67K | $131.59K | New |
| Q4 2023 | 97.77K | $131.01K | Add |
| Q1 2024 | 89.17K | $129.29K | Reduce |
| Q3 2024 | 274.49K | $259.97K | Add |
| Q4 2024 | 691.54K | $774.53K | Add |
| Q1 2025 | 685.30K | $1.02M | Reduce |
| Q2 2025 | 672.54K | $955.01K | Reduce |
| Q3 2025 | 666.04K | $2.19M | Reduce |
| Q1 2026 | 689.41K | $2.67M | Add |
| Q2 2026 | 638.41K | $3.64M | Reduce |
| Q3 2026 | 633.53K | $5.42M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PGEN and 13F data
PGEN (PRECIGEN INC) is a Health Care company. 58 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$108.5M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), Boxer Capital Management, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PGEN
- Patient Capital Management, LLC 19.04M sh · $108.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 6.42M sh · $36.58M · Q2 2026
- Boxer Capital Management, LLC 5.15M sh · $29.36M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 4.03M sh · $22.98M · Q2 2026
- Diametric Capital, LP 1.41M sh · $8.05M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 683.42K sh · $5.85M · Q3 2026
- GMT CAPITAL CORP 668.83K sh · $3.81M · Q2 2026
- Lansing Street Advisors 495.42K sh · $2.82M · Q2 2026
- Occam Crest Management LP 35.50K sh · $2.49M · Q2 2026
More on LexAurum Advisors, LLC
FAQ
How long has LexAurum Advisors, LLC held PGEN?
LexAurum Advisors, LLC has disclosed PGEN holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is LexAurum Advisors, LLC's current position in PGEN?
As of Q3 2026, LexAurum Advisors, LLC holds 633.53K shares of PGEN (PRECIGEN INC), valued at $5.42M, representing 0.61% of its reported portfolio and ranking #38.
Has LexAurum Advisors, LLC been buying or selling PGEN?
In the latest 13F filing (Q3 2026), LexAurum Advisors, LLC reduced its position in PGEN. The position peaked in Q3 2026 at 633.53K shares.
Which other funds hold PGEN?
Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.